Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong.

"Declarations Conflicts of interestThe authors have no relevant financial or non-financial interests to disclose. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. Ethical approvalThis study was approved by the Joint Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee (Ethics Committee Approval Number NTEC-2018-0563). Informed consentThe study does not include identifiable human or animal data requiring consent. Conflicts of interest The authors have no relevant financial or non-financial interests to disclose. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript."

"Funding This study was supported by the National Natural Science Foundation of China (NSFC) Grant Nos. 72042018, 71972164, and 71672163, in part by the Health and Medical Research Fund Grant (HMRF), the Food and Health Bureau, the Government of the Hong Kong Special Administrative Region No. 16171991, and in part by the Theme-Based Research Scheme of the Research Grants Council of Hong Kong Grant No. T32-102/14N."